Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of a Randomized Double-Blind Placebo-Controlled Trial

Irritable bowel syndrome (IBS) is a functional gastrointestinal disease in the pathogenesis of which gut dysbiosis may play an important role. Thus, probiotics, prebiotics, or microbiota metabolites, such as butyric acid, are considered to be effective therapy for IBS. However, there are still no tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gąsiorowska, Anita, Romanowski, Marek, Walecka-Kapica, Ewa, Kaczka, Aleksandra, Chojnacki, Cezary, Padysz, Milena, Siedlecka, Marta, Bierła, Joanna B., Steinert, Robert E., Cukrowska, Bożena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655302/
https://www.ncbi.nlm.nih.gov/pubmed/36362815
http://dx.doi.org/10.3390/jcm11216587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655302/
https://www.ncbi.nlm.nih.gov/pubmed/36362815
http://dx.doi.org/10.3390/jcm11216587

Ejemplares similares